BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyles TH, Brink A, Calligaro GL, Cohen C, Dheda K, Maartens G, Richards GA, van Zyl Smit R, Smith C, Wasserman S, Whitelaw AC, Feldman C; South African Thoracic Society., Federation of Infectious Diseases Societies of Southern Africa. South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis 2017;9:1469-502. [PMID: 28740661 DOI: 10.21037/jtd.2017.05.31] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Sharma R, Sandrock CE, Meehan J, Theriault N. Community-Acquired Bacterial Pneumonia-Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin. Clin Drug Investig 2020;40:947-60. [PMID: 32889706 DOI: 10.1007/s40261-020-00953-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Current Opinion in Pulmonary Medicine 2019;25:249-56. [DOI: 10.1097/mcp.0000000000000558] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stalteri Mastrangelo R, Santesso N, Bognanni A, Darzi A, Karam S, Piggott T, Baldeh T, Schünemann F, Ventresca M, Morgano GP, Moja L, Loeb M, Schunemann H. Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey. BMJ Open 2021;11:e046097. [PMID: 34330853 DOI: 10.1136/bmjopen-2020-046097] [Reference Citation Analysis]
4 Barberán J, Restrepo R, Cardinal-Fernández P. Community-acquired pneumonia: similarities and differences between European and American guidelines - A narrative review. Rev Esp Quimioter 2021;34:72-80. [PMID: 33291864 DOI: 10.37201/req/114.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zamparini J, Venturas J, Diana N. COVID-19 and the uniqueness of South Africa. S Afr J Infect Dis 2020;35:208. [PMID: 34192122 DOI: 10.4102/sajid.v35i1.208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Feldman C, Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections. F1000Res 2018;7:F1000 Faculty Rev-1121. [PMID: 30079235 DOI: 10.12688/f1000research.14226.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
7 Cillóniz C, García-Vidal C, Moreno A, Miro JM, Torres A. Community-acquired bacterial pneumonia in adult HIV-infected patients. Expert Rev Anti Infect Ther 2018;16:579-88. [PMID: 29976111 DOI: 10.1080/14787210.2018.1495560] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Chou CC, Shen CF, Chen SJ, Chen HM, Wang YC, Chang WS, Chang YT, Chen WY, Huang CY, Kuo CC, Li MC, Lin JF, Lin SP, Ting SW, Weng TC, Wu PS, Wu UI, Lin PC, Lee SS, Chen YS, Liu YC, Chuang YC, Yu CJ, Huang LM, Lin MC; Infectious Diseases Society of Taiwan;., Taiwan Society of Pulmonary and Critical Care Medicine,., Medical Foundation in Memory of Dr. Deh-Lin Cheng;., Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;., CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,., 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect 2019;52:172-99. [PMID: 30612923 DOI: 10.1016/j.jmii.2018.11.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
9 Tachiwada T, Noguchi S, Muramatsu K, Akata K, Yamasaki K, Kido T, Asakawa T, Fujino Y, Fushimi K, Matsuda S, Mukae H, Yatera K. Effects of additive corticosteroid therapy on 90-day survival in patients with community-onset pneumonia. J Infect Chemother 2021:S1341-321X(21)00348-2. [PMID: 34955409 DOI: 10.1016/j.jiac.2021.12.012] [Reference Citation Analysis]
10 Ma CM, Wang N, Su QW, Yan Y, Yin FZ. The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population. Diabetes Metab Syndr Obes 2021;14:1359-66. [PMID: 33790603 DOI: 10.2147/DMSO.S303124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wills NK, Lawrence DS, Botsile E, Tenforde MW, Jarvis JN. The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis. Med Mycol 2021;59:802-12. [PMID: 33578417 DOI: 10.1093/mmy/myab002] [Reference Citation Analysis]
12 Rachina S, Kozlov R, Kurkova A, Portnyagina U, Palyutin S, Khokhlov A, Reshetko O, Zhuravleva M, Palagin I; on behalf of Russian Working Group of the Project. Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic. Antibiotics 2022;11:586. [DOI: 10.3390/antibiotics11050586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nunes MC, Moreira M, Koen A, van Niekerk N, Jose L, Cutland CL, François N, Schoonbroodt S, Ruiz-Guiñazú J, Yarzabal JP, Borys D, Schuerman L, Madhi SA. Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Rev Vaccines 2020;19:1177-89. [PMID: 33245004 DOI: 10.1080/14760584.2020.1853533] [Reference Citation Analysis]
14 Feldman C, Dlamini SK, Madhi SA, Meiring S, von Gottberg A, de Beer JC, de Necker M, Stander MP. The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults. PLoS One 2020;15:e0227945. [PMID: 31995597 DOI: 10.1371/journal.pone.0227945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mazaza A, Lalla U, Taljaard JJ, John TJ, John KG, Slabbert J, Koegelenberg CFN. The aetiology of severe community-acquired pneumonia requiring intensive care unit admission in the Western Cape Province, South Africa. Afr J Thorac Crit Care Med 2020;26. [PMID: 34240018 DOI: 10.7196/AJTCCM.2020.v26i1.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Boyles TH, Brink A, Calligaro GL, Cohen C, Dheda K, Maartens G, Richards GA, van Zyl Smit R, Smith C, Wasserman S, Whitelaw AC, Feldman C; South African Thoracic Society., Federation of Infectious Diseases Societies of Southern Africa. Erratum to South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis 2018;10:E673-5. [PMID: 30233915 DOI: 10.21037/jtd.2018.07.137] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 van den Bergh D, Messina AP, Goff DA, van Jaarsveld A, Coetzee R, de Wet Y, Bronkhorst E, Brink A, Mendelson M, Richards GA, Feldman C, Schellack N; South African Antibiotic Stewardship Programme Pharmacist Community-acquired Pneumonia Study Alliance. A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa. Int J Antimicrob Agents 2020;56:106189. [PMID: 33045348 DOI: 10.1016/j.ijantimicag.2020.106189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ma CM, Wang N, Su QW, Yan Y, Yin FZ. Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes. Diabetes Metab Syndr Obes 2020;13:3617-26. [PMID: 33116713 DOI: 10.2147/DMSO.S268679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Venturas J, Zamparini J, Shaddock E, Stacey S, Murray L, Richards GA, Kalla I, Mahomed A, Mohamed F, Mer M, Maposa I, Feldman C. Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19. J Infect 2021;83:217-27. [PMID: 34051225 DOI: 10.1016/j.jinf.2021.05.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Aston SJ, Ho A, Jary H, Huwa J, Mitchell T, Ibitoye S, Greenwood S, Joekes E, Daire A, Mallewa J, Everett D, Nyirenda M, Faragher B, Mwandumba HC, Heyderman RS, Gordon SB. Etiology and Risk Factors for Mortality in an Adult Community-acquired Pneumonia Cohort in Malawi. Am J Respir Crit Care Med 2019;200:359-69. [PMID: 30625278 DOI: 10.1164/rccm.201807-1333OC] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
21 Cillóniz C, Miro JM, Torres A. Reply to Head and Keynan. Clin Infect Dis 2019;68:1433-4. [PMID: 30321334 DOI: 10.1093/cid/ciy894] [Reference Citation Analysis]
22 Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, du Toit B, Fredericks ES, Lekalakala-Mokaba MR, Maluleka C, Rajabally MN, Reubenson G, Shuping L, Swart K, Swe Han KS, Wadula J, Wojno J, Lowman W. South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 2020;35:219. [PMID: 34485483 DOI: 10.4102/sajid.v35i1.219] [Reference Citation Analysis]
23 Muller EE, Mahlangu MP, Lewis DA, Kularatne RS. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014. BMC Infect Dis 2019;19:148. [PMID: 30760230 DOI: 10.1186/s12879-019-3797-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
24 Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Curr Opin Infect Dis 2018;31:170-6. [PMID: 29373381 DOI: 10.1097/QCO.0000000000000435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Curr Opin Pulm Med 2021;27:210-5. [PMID: 33405483 DOI: 10.1097/MCP.0000000000000760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Huang J, Guo J, Li H, Huang W, Zhang T. Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14636. [PMID: 30921179 DOI: 10.1097/MD.0000000000014636] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
27 Nambafu J, Achakolong M, Mwendwa F, Bwika J, Riunga F, Gitau S, Patel H, Adam RD. A prospective observational study of community acquired pneumonia in Kenya: the role of viral pathogens. BMC Infect Dis 2021;21:703. [PMID: 34301184 DOI: 10.1186/s12879-021-06388-x] [Reference Citation Analysis]